 | • レポートコード：MRC2Q12-18010 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、核酸保存液のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 核酸保存液のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 核酸保存液の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 核酸保存液のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの核酸保存液の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の核酸保存液の売上および2028年までの予測に焦点を当てています。 核酸保存液のグローバル主要企業には、Thermo Fisher Scientific、Beyotime、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instrumentsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 核酸保存液市場は、タイプとアプリケーションによって区分されます。世界の核酸保存液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 不活化、非不活化 【アプリケーション別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 核酸保存液製品概要 - タイプ別市場（不活化、非不活化） - アプリケーション別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の核酸保存液販売量予測2017-2028 - 世界の核酸保存液売上予測2017-2028 - 核酸保存液の地域別販売量 - 核酸保存液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別核酸保存液販売量 - 主要メーカー別核酸保存液売上 - 主要メーカー別核酸保存液価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（不活化、非不活化） - 核酸保存液のタイプ別販売量 - 核酸保存液のタイプ別売上 - 核酸保存液のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック） - 核酸保存液のアプリケーション別販売量 - 核酸保存液のアプリケーション別売上 - 核酸保存液のアプリケーション別価格 ・北米市場 - 北米の核酸保存液市場規模（タイプ別、アプリケーション別） - 主要国別の核酸保存液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの核酸保存液市場規模（タイプ別、アプリケーション別） - 主要国別の核酸保存液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の核酸保存液市場規模（タイプ別、アプリケーション別） - 主要国別の核酸保存液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の核酸保存液市場規模（タイプ別、アプリケーション別） - 主要国別の核酸保存液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの核酸保存液市場規模（タイプ別、アプリケーション別） - 主要国別の核酸保存液市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Beyotime、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instruments ・産業チェーン及び販売チャネル分析 - 核酸保存液の産業チェーン分析 - 核酸保存液の原材料 - 核酸保存液の生産プロセス - 核酸保存液の販売及びマーケティング - 核酸保存液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 核酸保存液の産業動向 - 核酸保存液のマーケットドライバー - 核酸保存液の課題 - 核酸保存液の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Nucleic Acid Preservation Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Nucleic Acid Preservation Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Nucleic Acid Preservation Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Nucleic Acid Preservation Solution include Thermo Fisher Scientific, Beyotime, EKF Diagnostics Holdings, Mylab, Rapid Test Methods Ltd., CellTreat, Labnet, Foxx Life Sciences and Heathrow Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nucleic Acid Preservation Solution manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nucleic Acid Preservation Solution market. Further, it explains the major drivers and regional dynamics of the global Nucleic Acid Preservation Solution market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher Scientific
Beyotime
EKF Diagnostics Holdings
Mylab
Rapid Test Methods Ltd.
CellTreat
Labnet
Foxx Life Sciences
Heathrow Scientific
Motic Microscopy
VistaLab
Memmert
VH Bio Limited
Babio Corp
Improve Medical Instruments
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Nucleic Acid Preservation Solution Segment by Type
Inactivated
Non-inactivated
Nucleic Acid Preservation Solution Segment by Application
Hospital
Clinic
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nucleic Acid Preservation Solution market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nucleic Acid Preservation Solution, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nucleic Acid Preservation Solution, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Preservation Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nucleic Acid Preservation Solution sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Nucleic Acid Preservation Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Nucleic Acid Preservation Solution sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Beyotime, EKF Diagnostics Holdings, Mylab, Rapid Test Methods Ltd., CellTreat, Labnet, Foxx Life Sciences and Heathrow Scientific, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nucleic Acid Preservation Solution in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nucleic Acid Preservation Solution manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Preservation Solution sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Nucleic Acid Preservation Solution Product Introduction
1.2 Market by Type
1.2.1 Global Nucleic Acid Preservation Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated
1.2.3 Non-inactivated
1.3 Market by Application
1.3.1 Global Nucleic Acid Preservation Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nucleic Acid Preservation Solution Sales Estimates and Forecasts 2017-2028
2.2 Global Nucleic Acid Preservation Solution Revenue Estimates and Forecasts 2017-2028
2.3 Global Nucleic Acid Preservation Solution Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nucleic Acid Preservation Solution Sales by Region
2.4.1 Global Nucleic Acid Preservation Solution Sales by Region (2017-2022)
2.4.2 Global Sales Nucleic Acid Preservation Solution by Region (2023-2028)
2.5 Global Nucleic Acid Preservation Solution Revenue by Region
2.5.1 Global Nucleic Acid Preservation Solution Revenue by Region (2017-2022)
2.5.2 Global Nucleic Acid Preservation Solution Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nucleic Acid Preservation Solution Sales by Manufacturers
3.1.1 Global Top Nucleic Acid Preservation Solution Manufacturers by Sales (2017-2022)
3.1.2 Global Nucleic Acid Preservation Solution Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nucleic Acid Preservation Solution in 2021
3.2 Global Nucleic Acid Preservation Solution Revenue by Manufacturers
3.2.1 Global Nucleic Acid Preservation Solution Revenue by Manufacturers (2017-2022)
3.2.2 Global Nucleic Acid Preservation Solution Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nucleic Acid Preservation Solution Revenue in 2021
3.3 Global Nucleic Acid Preservation Solution Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nucleic Acid Preservation Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nucleic Acid Preservation Solution Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nucleic Acid Preservation Solution Sales by Type
4.1.1 Global Nucleic Acid Preservation Solution Historical Sales by Type (2017-2022)
4.1.2 Global Nucleic Acid Preservation Solution Forecasted Sales by Type (2023-2028)
4.1.3 Global Nucleic Acid Preservation Solution Sales Market Share by Type (2017-2028)
4.2 Global Nucleic Acid Preservation Solution Revenue by Type
4.2.1 Global Nucleic Acid Preservation Solution Historical Revenue by Type (2017-2022)
4.2.2 Global Nucleic Acid Preservation Solution Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nucleic Acid Preservation Solution Revenue Market Share by Type (2017-2028)
4.3 Global Nucleic Acid Preservation Solution Price by Type
4.3.1 Global Nucleic Acid Preservation Solution Price by Type (2017-2022)
4.3.2 Global Nucleic Acid Preservation Solution Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nucleic Acid Preservation Solution Sales by Application
5.1.1 Global Nucleic Acid Preservation Solution Historical Sales by Application (2017-2022)
5.1.2 Global Nucleic Acid Preservation Solution Forecasted Sales by Application (2023-2028)
5.1.3 Global Nucleic Acid Preservation Solution Sales Market Share by Application (2017-2028)
5.2 Global Nucleic Acid Preservation Solution Revenue by Application
5.2.1 Global Nucleic Acid Preservation Solution Historical Revenue by Application (2017-2022)
5.2.2 Global Nucleic Acid Preservation Solution Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nucleic Acid Preservation Solution Revenue Market Share by Application (2017-2028)
5.3 Global Nucleic Acid Preservation Solution Price by Application
5.3.1 Global Nucleic Acid Preservation Solution Price by Application (2017-2022)
5.3.2 Global Nucleic Acid Preservation Solution Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Preservation Solution Market Size by Type
6.1.1 North America Nucleic Acid Preservation Solution Sales by Type (2017-2028)
6.1.2 North America Nucleic Acid Preservation Solution Revenue by Type (2017-2028)
6.2 North America Nucleic Acid Preservation Solution Market Size by Application
6.2.1 North America Nucleic Acid Preservation Solution Sales by Application (2017-2028)
6.2.2 North America Nucleic Acid Preservation Solution Revenue by Application (2017-2028)
6.3 North America Nucleic Acid Preservation Solution Market Size by Country
6.3.1 North America Nucleic Acid Preservation Solution Sales by Country (2017-2028)
6.3.2 North America Nucleic Acid Preservation Solution Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nucleic Acid Preservation Solution Market Size by Type
7.1.1 Europe Nucleic Acid Preservation Solution Sales by Type (2017-2028)
7.1.2 Europe Nucleic Acid Preservation Solution Revenue by Type (2017-2028)
7.2 Europe Nucleic Acid Preservation Solution Market Size by Application
7.2.1 Europe Nucleic Acid Preservation Solution Sales by Application (2017-2028)
7.2.2 Europe Nucleic Acid Preservation Solution Revenue by Application (2017-2028)
7.3 Europe Nucleic Acid Preservation Solution Market Size by Country
7.3.1 Europe Nucleic Acid Preservation Solution Sales by Country (2017-2028)
7.3.2 Europe Nucleic Acid Preservation Solution Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nucleic Acid Preservation Solution Market Size by Type
8.1.1 Asia Pacific Nucleic Acid Preservation Solution Sales by Type (2017-2028)
8.1.2 Asia Pacific Nucleic Acid Preservation Solution Revenue by Type (2017-2028)
8.2 Asia Pacific Nucleic Acid Preservation Solution Market Size by Application
8.2.1 Asia Pacific Nucleic Acid Preservation Solution Sales by Application (2017-2028)
8.2.2 Asia Pacific Nucleic Acid Preservation Solution Revenue by Application (2017-2028)
8.3 Asia Pacific Nucleic Acid Preservation Solution Market Size by Region
8.3.1 Asia Pacific Nucleic Acid Preservation Solution Sales by Region (2017-2028)
8.3.2 Asia Pacific Nucleic Acid Preservation Solution Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nucleic Acid Preservation Solution Market Size by Type
9.1.1 Latin America Nucleic Acid Preservation Solution Sales by Type (2017-2028)
9.1.2 Latin America Nucleic Acid Preservation Solution Revenue by Type (2017-2028)
9.2 Latin America Nucleic Acid Preservation Solution Market Size by Application
9.2.1 Latin America Nucleic Acid Preservation Solution Sales by Application (2017-2028)
9.2.2 Latin America Nucleic Acid Preservation Solution Revenue by Application (2017-2028)
9.3 Latin America Nucleic Acid Preservation Solution Market Size by Country
9.3.1 Latin America Nucleic Acid Preservation Solution Sales by Country (2017-2028)
9.3.2 Latin America Nucleic Acid Preservation Solution Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nucleic Acid Preservation Solution Market Size by Type
10.1.1 Middle East and Africa Nucleic Acid Preservation Solution Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nucleic Acid Preservation Solution Revenue by Type (2017-2028)
10.2 Middle East and Africa Nucleic Acid Preservation Solution Market Size by Application
10.2.1 Middle East and Africa Nucleic Acid Preservation Solution Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nucleic Acid Preservation Solution Revenue by Application (2017-2028)
10.3 Middle East and Africa Nucleic Acid Preservation Solution Market Size by Country
10.3.1 Middle East and Africa Nucleic Acid Preservation Solution Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nucleic Acid Preservation Solution Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Beyotime
11.2.1 Beyotime Corporation Information
11.2.2 Beyotime Overview
11.2.3 Beyotime Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Beyotime Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Beyotime Recent Developments
11.3 EKF Diagnostics Holdings
11.3.1 EKF Diagnostics Holdings Corporation Information
11.3.2 EKF Diagnostics Holdings Overview
11.3.3 EKF Diagnostics Holdings Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EKF Diagnostics Holdings Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EKF Diagnostics Holdings Recent Developments
11.4 Mylab
11.4.1 Mylab Corporation Information
11.4.2 Mylab Overview
11.4.3 Mylab Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylab Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylab Recent Developments
11.5 Rapid Test Methods Ltd.
11.5.1 Rapid Test Methods Ltd. Corporation Information
11.5.2 Rapid Test Methods Ltd. Overview
11.5.3 Rapid Test Methods Ltd. Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rapid Test Methods Ltd. Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rapid Test Methods Ltd. Recent Developments
11.6 CellTreat
11.6.1 CellTreat Corporation Information
11.6.2 CellTreat Overview
11.6.3 CellTreat Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CellTreat Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CellTreat Recent Developments
11.7 Labnet
11.7.1 Labnet Corporation Information
11.7.2 Labnet Overview
11.7.3 Labnet Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Labnet Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Labnet Recent Developments
11.8 Foxx Life Sciences
11.8.1 Foxx Life Sciences Corporation Information
11.8.2 Foxx Life Sciences Overview
11.8.3 Foxx Life Sciences Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Foxx Life Sciences Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Foxx Life Sciences Recent Developments
11.9 Heathrow Scientific
11.9.1 Heathrow Scientific Corporation Information
11.9.2 Heathrow Scientific Overview
11.9.3 Heathrow Scientific Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Heathrow Scientific Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Heathrow Scientific Recent Developments
11.10 Motic Microscopy
11.10.1 Motic Microscopy Corporation Information
11.10.2 Motic Microscopy Overview
11.10.3 Motic Microscopy Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Motic Microscopy Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Motic Microscopy Recent Developments
11.11 VistaLab
11.11.1 VistaLab Corporation Information
11.11.2 VistaLab Overview
11.11.3 VistaLab Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 VistaLab Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 VistaLab Recent Developments
11.12 Memmert
11.12.1 Memmert Corporation Information
11.12.2 Memmert Overview
11.12.3 Memmert Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Memmert Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Memmert Recent Developments
11.13 VH Bio Limited
11.13.1 VH Bio Limited Corporation Information
11.13.2 VH Bio Limited Overview
11.13.3 VH Bio Limited Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 VH Bio Limited Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 VH Bio Limited Recent Developments
11.14 Babio Corp
11.14.1 Babio Corp Corporation Information
11.14.2 Babio Corp Overview
11.14.3 Babio Corp Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Babio Corp Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Babio Corp Recent Developments
11.15 Improve Medical Instruments
11.15.1 Improve Medical Instruments Corporation Information
11.15.2 Improve Medical Instruments Overview
11.15.3 Improve Medical Instruments Nucleic Acid Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Improve Medical Instruments Nucleic Acid Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Improve Medical Instruments Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nucleic Acid Preservation Solution Industry Chain Analysis
12.2 Nucleic Acid Preservation Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nucleic Acid Preservation Solution Production Mode & Process
12.4 Nucleic Acid Preservation Solution Sales and Marketing
12.4.1 Nucleic Acid Preservation Solution Sales Channels
12.4.2 Nucleic Acid Preservation Solution Distributors
12.5 Nucleic Acid Preservation Solution Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nucleic Acid Preservation Solution Industry Trends
13.2 Nucleic Acid Preservation Solution Market Drivers
13.3 Nucleic Acid Preservation Solution Market Challenges
13.4 Nucleic Acid Preservation Solution Market Restraints
14 Key Findings in The Global Nucleic Acid Preservation Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer